No easy way to exterminate 'superbugs' at the dawn of the third millennium

Expert Review of Anti-Infective Therapy

Volumn 1, Issue 4, 2003, Pages 523-525

  Pirnay, Jean Paul ^a   De Vos, Daniel ^a   Zizi, Martin ^a,b   Heyman, Paul ^a  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDE;

ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; CHROMOSOME MUTATION; CULTURAL ANTHROPOLOGY; DOCTOR PATIENT RELATION; DRUG UTILIZATION; EDITORIAL; ENVIRONMENTAL CHANGE; EPIDEMIC; EVIDENCE BASED MEDICINE; GENOTYPE; GEOGRAPHY; HEALTH BEHAVIOR; HEALTH CARE; HUMAN; MEDICAL EDUCATION; MOLECULAR CLONING; MONITORING; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH; RELIGION; SOCIAL ASPECT; TRAINING;

EID: 3042696615     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: 10.1586/14787210.1.4.523     Document Type: Editorial

References (15)

1. Pirnay JP, De Vos D, Cochez C et al. Pseudomonas aeruginosa displays an epidemic population structure. Environ. Microbiol. 4, 898-911 (2002).
2. Lenski RE. Bacterial evolution and the cost of antibiotic resistance. Int. Microbiol. 1, 265-270 (1998).
3. Enne VI, Livermore DM, Stephens P, Hall LMC. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357, 1325-1328 (2001).
4. Salyers AA and Amábile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrob. Agents Chemother. 41, 2321-2325 (1997).
5. Cunha BA. Strategies to control antibiotic resistance. Semin. Respir. Infect. 17, 250-258 (2002).
6. Carmelli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 43, 1379-1382 (1999).
7. Stratton CW. Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg. Infect. Dis. 9, 10-16 (2003).
8. Bergeron MG, Ouellette M. Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory. J. Clin. Microbiol. 36, 2169-2172 (1998).
9. Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM. Cross-cultural differences in lay attitudes and utilization of antibiotics in a Belgian and a Dutch city. Patient Educat. Counsel. 48, 161-169 (2002).
10. Harbarth S, Albrich W, Brun-Buisson C. Out-patient antibiotic use and prevalence of antibiotic-resistant Pneumococci in France and Germany: a sociocultural perspective. Emerg. Infect. Dis. 8, 1460-1467 (2002).
11. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 357, 1851-1853 (2001).
12. Bronzwaer SL, Cars O, Buchholz UK et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8, 278-282 (2002).
13. Hanberger H, Diekema D, Fluit A et al. Surveillance of antibiotic resistance in European ICUs. J. Hosp. Infect. 48, 161-176 (2001).
14. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274, 639-644 (1995).
15. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13, 50-55 (1994).